🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested
This study will evaluate the safety and efficacy of a prostate cancer vacci...
Status
Unknown
Location
Beth Israel Deaconess Medical Center
Start Date
2019-02-28
Trial ID
NCT03579654
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
Background: * The National Cancer Institute (NCI) Surgery Branch has devel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-12-12
Trial ID
NCT01993719
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2020-02-19
Trial ID
NCT04155710
Treatments Being Tested
The immune system has offensive and defensive capacities. In bone marrow tr...
Status
Terminated
Location
Katholieke Universiteit Leuven
Start Date
2013-07
Trial ID
NCT01903473
Treatments Being Tested
Study aims at evaluating the therapeutic efficacy and safety of low-dose IL...
Status
Active Not Recruiting
Location
GHU Saint Anne
Start Date
2022-10-11
Trial ID
NCT05468073
Monoclonal antibodies such as rituximab can locate cancer cells and either ...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2000-12
Trial ID
NCT00010192
Treatments Being Tested
MIROCALS is a phase II study of ld-IL-2 as a therapeutic agent for ALS. A r...
Status
Completed
Location
CHRU de Lille - Hôpital Roger Salengro
Start Date
2017-06-19
Trial ID
NCT03039673
Treatments Being Tested
The objective of this clinical study is to evaluate the potential effect of...
Status
Completed
Location
Department of Rheumatology and Immunology, Peking University People's Hospital
Start Date
2016-05-05
Trial ID
NCT02932137
Treatments Being Tested